Free Trial

Marsh & McLennan Companies, Inc. (NYSE:MMC) Shares Sold by Envestnet Portfolio Solutions Inc.

Marsh & McLennan Companies logo with Finance background
Remove Ads

Envestnet Portfolio Solutions Inc. trimmed its holdings in shares of Marsh & McLennan Companies, Inc. (NYSE:MMC - Free Report) by 17.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 37,961 shares of the financial services provider's stock after selling 8,153 shares during the quarter. Envestnet Portfolio Solutions Inc.'s holdings in Marsh & McLennan Companies were worth $8,063,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. Financial Life Planners bought a new stake in Marsh & McLennan Companies during the 4th quarter valued at $33,000. Sierra Ocean LLC purchased a new position in shares of Marsh & McLennan Companies during the fourth quarter valued at $36,000. Albion Financial Group UT purchased a new stake in Marsh & McLennan Companies in the fourth quarter worth about $38,000. Golden State Wealth Management LLC bought a new position in Marsh & McLennan Companies during the 4th quarter worth about $41,000. Finally, Halbert Hargrove Global Advisors LLC purchased a new position in Marsh & McLennan Companies during the 4th quarter valued at about $45,000. 87.99% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other news, CEO Nicholas Mark Studer sold 49,390 shares of the business's stock in a transaction dated Wednesday, March 12th. The stock was sold at an average price of $230.16, for a total value of $11,367,602.40. Following the completion of the transaction, the chief executive officer now owns 28,329 shares of the company's stock, valued at $6,520,202.64. The trade was a 63.55 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Dean Michael Klisura sold 7,121 shares of the firm's stock in a transaction dated Monday, March 10th. The stock was sold at an average price of $234.97, for a total value of $1,673,221.37. Following the sale, the chief executive officer now directly owns 20,935 shares in the company, valued at approximately $4,919,096.95. This trade represents a 25.38 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 57,828 shares of company stock valued at $13,350,279 in the last ninety days. Insiders own 0.30% of the company's stock.

Remove Ads

Analysts Set New Price Targets

A number of research firms have recently issued reports on MMC. Keefe, Bruyette & Woods dropped their price objective on shares of Marsh & McLennan Companies from $214.00 to $210.00 and set an "underperform" rating on the stock in a research note on Monday, February 3rd. Evercore ISI reaffirmed an "outperform" rating and set a $242.00 target price on shares of Marsh & McLennan Companies in a research report on Monday, November 25th. Royal Bank of Canada raised Marsh & McLennan Companies from a "sector perform" rating to an "outperform" rating and boosted their price target for the stock from $242.00 to $250.00 in a research report on Thursday, December 12th. JPMorgan Chase & Co. raised their price objective on Marsh & McLennan Companies from $230.00 to $235.00 and gave the company a "neutral" rating in a research report on Friday, January 3rd. Finally, Barclays boosted their target price on shares of Marsh & McLennan Companies from $236.00 to $246.00 and gave the stock an "equal weight" rating in a report on Thursday, November 21st. Two investment analysts have rated the stock with a sell rating, ten have given a hold rating and four have given a buy rating to the stock. According to MarketBeat, Marsh & McLennan Companies presently has a consensus rating of "Hold" and a consensus price target of $230.44.

View Our Latest Report on MMC

Marsh & McLennan Companies Stock Performance

Shares of NYSE:MMC traded down $1.32 on Friday, hitting $232.05. 3,067,065 shares of the company were exchanged, compared to its average volume of 1,641,752. The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 1.44. The stock's 50 day moving average price is $226.65 and its 200 day moving average price is $223.79. Marsh & McLennan Companies, Inc. has a 1-year low of $196.17 and a 1-year high of $241.84. The firm has a market capitalization of $113.97 billion, a P/E ratio of 28.33, a price-to-earnings-growth ratio of 2.70 and a beta of 0.95.

Marsh & McLennan Companies (NYSE:MMC - Get Free Report) last posted its quarterly earnings results on Thursday, January 30th. The financial services provider reported $1.87 earnings per share for the quarter, beating the consensus estimate of $1.75 by $0.12. Marsh & McLennan Companies had a return on equity of 32.60% and a net margin of 16.60%. Sell-side analysts predict that Marsh & McLennan Companies, Inc. will post 9.61 EPS for the current year.

Marsh & McLennan Companies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, May 15th. Shareholders of record on Thursday, April 3rd will be paid a dividend of $0.815 per share. This represents a $3.26 annualized dividend and a yield of 1.40%. The ex-dividend date is Thursday, April 3rd. Marsh & McLennan Companies's payout ratio is 39.80%.

About Marsh & McLennan Companies

(Free Report)

Marsh & McLennan Cos., Inc is a professional services firm, which engages in offering clients advice and solutions in risk, strategy, and people. It operates through the Risk and Insurance Services, and Consulting segments. The Risk and Insurance Services segment is involved in risk management activities, as well as insurance and reinsurance broking and services.

Featured Stories

Institutional Ownership by Quarter for Marsh & McLennan Companies (NYSE:MMC)

Should You Invest $1,000 in Marsh & McLennan Companies Right Now?

Before you consider Marsh & McLennan Companies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marsh & McLennan Companies wasn't on the list.

While Marsh & McLennan Companies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
Why Palantir’s Future Just Got a Massive Boost

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads